---
title: NLGN4X TCR transgenic T cells to treat gliomas
date: '2023-09-16'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37715782/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230917180952&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSION: NLGN4X-TCR-T demonstrates efficacy in a preclinical glioblastoma
  model. On a global scale, we provide first evidence for the therapeutic retrieval
  of vaccine-induced human TCRs for the off-the-shelf treatment of glioblastoma ...'
disable_comments: true
---
CONCLUSION: NLGN4X-TCR-T demonstrates efficacy in a preclinical glioblastoma model. On a global scale, we provide first evidence for the therapeutic retrieval of vaccine-induced human TCRs for the off-the-shelf treatment of glioblastoma ...